Breast Ductal Carcinoma In Situ — Trials

Breast Ductal Carcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 51
Recruiting: 27
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03077841	Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	suspended	Phase 2 / Phase 3	928	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT06538389	High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer	suspended	Phase 2	36	City of Hope Medical CenterOTHER	1	Jul 14, 2026	clinicaltrials